FIELD: medicine, pharmaceutical technology, pharmacy.
SUBSTANCE: invention relates to a pharmaceutical composition containing calcium blocking agent and pharmacologically acceptable alkaline material that is added in the amount providing pH value of an aqueous solution or dispersion solution of indicated pharmaceutical composition at least 8. The composition shows excellent stability in storing, rapid absorption in digestive tract and it can be prepared easily by method of wet granulation.
EFFECT: valuable pharmaceutical properties of composition.
27 cl, 4 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CYCLIC AMINODERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATMENT AND PROPHYLAXIS OF DISEASES | 1997 |
|
RU2163596C2 |
| NOVEL PYRAZOLO[3,4-D]PYRIMIDINE COMPOUND OR SALT THEREOF | 2016 |
|
RU2705579C2 |
| NEW AMINOPYRIMIDINE DERIVATIVES AS PLK1 INHIBITORS | 2007 |
|
RU2458062C2 |
| PREVENTIVE OR THERAPEUTIC REMEDY FOR PHOTODERMATOSIS | 2021 |
|
RU2812785C1 |
| AGENT FOR TREATMENT OF ERECTILE FUNCTION | 1999 |
|
RU2229885C2 |
| T-TYPE CALCIUM CHANNEL-BLOCKING AGENT | 2004 |
|
RU2326886C2 |
| NEW URACIL COMPOUND OR SALT THEREOF POSSESSING HUMAN DEOXYURIDINE TRIPHOSPHATASE | 2009 |
|
RU2495873C2 |
| 4-PIPERAZIN-1-YL-4-BENZO[b]THIOPHENE DERIVATIVES, SUITABLE FOR TREATING CENTRAL NERVOUS SYSTEM DISORDERS | 2006 |
|
RU2415854C2 |
| ANTITUMOR EFFECT STRENGTHENING AGENT USING PYRAZOLO[3,4-d]PYRIMIDINE COMPOUND | 2018 |
|
RU2799006C2 |
| NOVEL PYRROLIDINE COMPOUND AND APPLICATION AS MELANOCORTIN RECEPTOR AGONIST | 2015 |
|
RU2669938C2 |
